Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

被引：182

作者：

Yuan, Xun ^{[1
]}

Wu, Hua ^{[1
]}

Han, Na ^{[1
]}

Xu, Hanxiao ^{[1
]}

Chu, Qian ^{[1
]}

Yu, Shiying ^{[1
]}

Chen, Yuan ^{[1
]}

Wu, Kongming ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Bldg 303,1095 Jie Fang Ave, Wuhan 430030, Peoples R China

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2014年 / 7卷

基金：

美国国家科学基金会;

关键词：

Notch signaling; Epithelial-mesenchymal transition (EMT); Cancer stem cells (CSCs); Non-small-cell lung cancer (NSCLC); Gamma secretase inhibitor; EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-SECRETASE INHIBITOR; CYCLIN D1; TGF-BETA; POOR-PROGNOSIS; TUMOR-GROWTH; STEM-CELLS; E-CADHERIN; IN-VITRO; PHASE-I;

D O I：

10.1186/s13045-014-0087-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Through epithelial-mesenchymal transition (EMT), cancer cells acquire enhanced ability of migration and invasion, stem cell like characteristics and therapeutic resistance. Notch signaling regulates cell-cell connection, cell polarity and motility during organ development. Recent studies demonstrate that Notch signaling plays an important role in lung cancer initiation and cross-talks with several transcriptional factors to enhance EMT, contributing to the progression of non-small cell lung cancer (NSCLC). Correspondingly, blocking of Notch signaling inhibits NSCLC migration and tumor growth by reversing EMT. Clinical trials have showed promising effect in some cancer patients received treatment with Notch1 inhibitor. This review attempts to provide an overview of the Notch signal in NSCLC: its biological significance and therapeutic application.

引用

页数：10

共 50 条

[1] Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
Xun Yuan
Hua Wu
Na Han
Hanxiao Xu
Qian Chu
Shiying Yu
Yuan Chen
Kongming Wu
Journal of Hematology & Oncology, 7
[2] Notch signaling and non-small cell lung cancer (Review)
Zou, Bin
Zhou, Xue-Liang
Lai, Song-Qing
Liu, Ji-Chun
ONCOLOGY LETTERS, 2018, 15 (03) : 3415 - 3421
[3] Notch signaling and targeted therapy in non-small cell lung cancer
Sun, Jiajun
Dong, Meichen
Xiang, Xin
Zhang, Shubing
Wen, Doudou
CANCER LETTERS, 2024, 585
[4] The roles of Notch signaling in the development of non-small cell lung cancer
Osanyingbemi-Obidi, Joyce O.
Rudin, Charles M.
CANCER RESEARCH, 2011, 71
[5] Prognostic significance of Notch ligands in patients with non-small cell lung cancer
Pancewicz-Wojtkiewicz, Joanna
Eljaszewicz, Andrzej
Kowalczuk, Oksana
Niklinska, Wieslawa
Charkiewicz, Radoslaw
Kozlowski, Miroslaw
Miasko, Agnieszka
Moniuszko, Marcin
ONCOLOGY LETTERS, 2017, 13 (01) : 506 - 510
[6] Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer
Jin, Meng-Meng
Ye, Yuan-Zi
Qian, Zhen-Dong
Zhang, Yan-Bei
ONCOLOGY LETTERS, 2015, 10 (05) : 3252 - 3260
[7] Notch Transduction in Non-Small Cell Lung Cancer
Sharif, Amnah
Shaji, Ann
Chammaa, May
Pawlik, Eileen
Fernandez-Valdivia, Rodrigo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 27
[8] Notch Signal In Non-Small Cell Lung Cancer
Chen, C. -Y.
Yu, C. -J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[9] Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer
O'Leary, Karen
Shia, Alice
Schmid, Peter
CURRENT CANCER DRUG TARGETS, 2018, 18 (01) : 89 - 96
[10] CLINICOPATHOLOGICAL AND BIOLOGICAL SIGNIFICANCE OF EPIREGULIN EXPRESSION IN NON-SMALL CELL LUNG CANCER
Sunaga, Noriaki
Tomizawa, Yoshio
Shimizu, Kimihiro
Imai, Hisao
Takahashi, Gen
Kakegawa, Seiichi
Ohtaki, Yoichi
Nagashima, Toshiteru
Kawashima, Osamu
Shames, David S.
Girard, Luc
Soh, Junichi
Sato, Mitsuo
Kaira, Kyoichi
Hisada, Takeshi
Gazdar, Adi F.
Minna, John
Yamada, Masanobu
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S426 - S427

← 1 2 3 4 5 →